MAR 15, 2017 09:00 AM PDT
Keynote Presentation - Prefrontal GABA regulation of cognition: implications for psychiatric disorders
Presented at the Neuroscience 2017 Virtual Event
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
3 2 146

Speakers:
  • Professor, Department of Psychology, University of British Columbia
    Biography
      Dr. Stan Floresco is a Professor of Psychology and member of the Brain Research Centre at the University of British Columbia, and a Fellow of the American College of Neuropsychopharmacology. He received his all of his postgraduate degrees from the UBC, obtaining his Ph.D in 2000. He subsequently conducted postdoctoral research in the Department of Neuroscience at the University of Pittsburgh, after which he returned to UBC to take up a faculty position in 2003..

      Dr. Floresco has published over 90 peer-reviewed articles on his research employing behavioral and neurophysiological approaches to study neural circuits within the dopamine system that facilitate higher-order cognitive functions such as cognitive flexibility and cost/benefit decision making, and how dysfunction in these circuits may relate to psychiatric disease. He currently serves as an associate editor for the journals Cognitive, Affective and Behavioral Neuroscience and Neuropsychopharmacology, and in 2010, he was awarded the American Psychological Association's Early Career Award.

    Abstract:

    The idea of schizophrenia typically conjures up images of people who hear voices, see visions and have delusional beliefs. However, clinicians have long recognized cognitive dysfunction as one of the most fundamental and debilitating aspects of the disorder.  Among the numerous brain abnormalities thought to underlie these symptoms, perturbations of the inhibitory neurotransmitter GABA within the frontal lobes are some of the most reliable alterations observed in the post-mortem brains of schizophrenic patients. These alterations may result in a hyperactive or ‘noisy’ cortex that may impair attention and other cognitive functions regulated by the frontal lobes.  However, our understanding of exactly how prefrontal cortical GABA may regulate these different aspects of cognition is sparse.  To better understand how these pathophysiological alterations may contribute to schizophrenia symptomology, work by our group has investigated how GABA transmission within the prefrontal cortex of rodents regulates a variety of cognitive, emotional and motivational functions known to be impaired in schizophrenia, using translational assays similar to those used with human patients.  Our findings indicate that reducing prefrontal GABA transmission recapitulates many of the cognitive, behavioural and dopaminergic abnormalities associated with schizophrenia, suggesting that dysfunction within this system may be a major contributing factor to variety of symptoms of the disorder.

     

    Learning objectives

    -Describe the evidence for dysfunction of inhibitory (GABAergic) transmission in schizophrenia

    -Explain how prefrontal cortical GABA transmission regulates a variety of cognitive and executive functions

    -Explore how translational research with animals can elucidate the neuropathology underlying mental illness


    Show Resources
    Loading Comments...